Jun. 08, 2026
-
Expanding the Potential of
Nucleic Acid Therapeutics
through Peptide Technology
Our Mission
Leading the World in Novel
Nucleic Acid Delivery Technology
Using Peptides
Developing proprietary peptide nanoparticles
for nucleic acid delivery.
We aim to efficiently deliver nucleic acid therapeutics
to target tissues.
Merits of Peptide Nanoparticles
Peptide Nanoparticles for
Targeted Delivery of Nucleic Acid Therapeutics
PNPs significantly reduce liver accumulation,
a key limitation of conventional delivery technologies.
Furthermore, we have demonstrated enhanced tissue selectivity by incorporating target-binding peptides into the PNP platform.
